SOCS5 and chronic myelogenous leukemia, BCR-ABL1 positive: A previous study showed that Leonurine plays an anti-leukemia role by inhibiting the proliferation, migration and colony formation of chronic myeloid leukemia cells and promoting their apoptosis through the miR-18a-5p/SOCS5/JAK2/STAT3 axis [11].